Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8313)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 8, 2015 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Perumpail RB, Liu A, Wong RJ, Ahmed A, Harrison SA. Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathways. World J Hepatol 2015; 7(22): 2384-2388 [PMID: 26464753 DOI: 10.4254/wjh.v7.i22.2384] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i22/2384.htm |
| Number | Citing Articles |
| 1 |
V. P. Prysyazhnyuk, Z. I. Rossokha, N. G. Gorovenko. Variation in particular biochemical indicators, cytokine and adipokine profiles of the blood, and the structural and functional parameters of the liver in patients with nonalcoholic fatty liver disease and different genotypes by the polymorphic locus A313G of the GSTP1 gene. Cytology and Genetics 2017; 51(6): 455 doi: 10.3103/S0095452717060111
|
| 2 |
Abhilash Perisetti, Hemant Goyal, Rachana Yendala, Ragesh B Thandassery, Emmanouil Giorgakis. Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements. World Journal of Gastroenterology 2021; 27(24): 3466-3482 doi: 10.3748/wjg.v27.i24.3466
|
| 3 |
Yu-Wen Su, Po-Hong Liu, Chia-Yang Hsu, Yun-Hsuan Lee, Cheng-Yuan Hsia, Shu-Yein Ho, Ming-Chih Hou, Harn-Shen Chen, Teh-Ia Huo, Sheng-Nan Lu. Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective. PLOS ONE 2017; 12(3): e0174333 doi: 10.1371/journal.pone.0174333
|
| 4 |
Pegah Golabi, James Paik, Natsu Fukui, Cameron T. Locklear, Leyla de Avilla, Zobair M. Younossi. Patients With Lean Nonalcoholic Fatty Liver Disease Are Metabolically Abnormal and Have a Higher Risk for Mortality. Clinical Diabetes 2019; 37(1): 65 doi: 10.2337/cd18-0026
|
| 5 |
Ozlem Kucukoglu, Jan-Peter Sowa, Guillermo Daniel Mazzolini, Wing-Kin Syn, Ali Canbay. Hepatokines and adipokines in NASH-related hepatocellular carcinoma. Journal of Hepatology 2021; 74(2): 442 doi: 10.1016/j.jhep.2020.10.030
|
| 6 |
Meenakshi Vachher, Savita Bansal, Bhupender Kumar, Sandeep Yadav, Archana Burman. Deciphering the role of aberrant DNA methylation in NAFLD and NASH. Heliyon 2022; 8(10): e11119 doi: 10.1016/j.heliyon.2022.e11119
|
| 7 |
Luca Rinaldi, Fabio Nascimbeni, Mauro Giordano, Chiara Masetti, Barbara Guerrera, Annalisa Amelia, Maria Chiara Fascione, Stefano Ballestri, Dante Romagnoli, Rosa Zampino, Riccardo Nevola, Enrica Baldelli, Natalina Iuliano, Valerio Rosato, Amedeo Lonardo, Luigi Elio Adinolfi. Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. World Journal of Gastroenterology 2017; 23(8): 1458-1468 doi: 10.3748/wjg.v23.i8.1458
|
| 8 |
Georgi Atanasov, Karoline Dino, Katrin Schierle, Corinna Dietel, Gabriela Aust, Johann Pratschke, Daniel Seehofer, Moritz Schmelzle, Hans-Michael Hau. Angiogenic inflammation and formation of necrosis in the tumor microenvironment influence patient survival after radical surgery for de novo hepatocellular carcinoma in non-cirrhosis. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1756-8
|
| 9 |
Ryota Masuzaki, Seth J. Karp, Masao Omata. NAFLD as a risk factor for HCC: new rules of engagement?. Hepatology International 2016; 10(4): 533 doi: 10.1007/s12072-016-9731-8
|
| 10 |
Fahimeh Tabakhiyan, Amirabbas Mir, Vahid Vahedian. Potential tumor marker for hepatocellular carcinoma identification: PI3K and pro-inflammatory cytokines (TGF-β, IL-1, and IL-6). Hormone Molecular Biology and Clinical Investigation 2022; 43(4): 389 doi: 10.1515/hmbci-2022-0028
|
| 11 |
Shenghu Feng, Ming Han, Li Zhou, Qi Wang, Zhongshu Li, Yaru Li, Hongping Lu, Ting Liu, Yanhua Ma, Shunai Liu, Jun Cheng. NS5ABP37 inhibits liver cancer by impeding lipogenesis and cholesterogenesis. Cancer Science 2017; 108(1): 12 doi: 10.1111/cas.13117
|
| 12 |
Chee-Kiat Tan. Peretinoin as an adjuvant therapy for hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2016; 10(11): 1201 doi: 10.1080/17474124.2016.1238303
|
| 13 |
Max Kabolowsky, Lyndsey Nguyen, Brett E. Fortune, Ernesto Santos, Sirish Kishore, Juan C. Camacho. Interventional Management of Portal Hypertension in Cancer Patients. Current Oncology Reports 2022; 24(11): 1461 doi: 10.1007/s11912-022-01319-8
|
| 14 |
Kanokwan Pinyopornpanish, Wael Al-Yaman, Srinivasan Dasarathy, Carlos Romero-Marrero, Arthur McCullough. Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival. Digestive Diseases and Sciences 2022; 67(6): 2677 doi: 10.1007/s10620-021-07048-5
|
| 15 |
Rupie Jamwal, Venkatram Krishnan, Dinesh Singh Kushwaha, Rajat Khurana. Hepatocellular carcinoma in non-cirrhotic versus cirrhotic liver: a clinico-radiological comparative analysis. Abdominal Radiology 2020; 45(8): 2378 doi: 10.1007/s00261-020-02561-z
|
| 16 |
Nikolaos-Andreas T. Anastasopoulos, Georgios D. Lianos, Vera Tatsi, Anastasia Karampa, Anna Goussia, Georgios K. Glantzounis. Clinical heterogeneity in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2020; 14(11): 1025 doi: 10.1080/17474124.2020.1802244
|
| 17 |
Qiong Wu, Jin-xian Chen, Yu Chen, Li-li Cai, Xiao-zhong Wang, Wu-hua Guo, Jian-feng Zheng. The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation. Cell Death & Disease 2018; 9(2) doi: 10.1038/s41419-018-0267-9
|
| 18 |
Elizabeth R. M. Zunica, Elizabeth C. Heintz, Christopher L. Axelrod, John P. Kirwan. Obesity Management in the Primary Prevention of Hepatocellular Carcinoma. Cancers 2022; 14(16): 4051 doi: 10.3390/cancers14164051
|
| 19 |
Eleanna Kaffe, Christiana Magkrioti, Vassilis Aidinis. Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer. Cancers 2019; 11(11): 1626 doi: 10.3390/cancers11111626
|
| 20 |
А.М. Абд Эль-Хамид, А.И. Юсеф, С.М. Абд Эль-Тваб, А.А.Г. Эль-Шахави, А. Абдель-Монеим. Гепатопротекторное действие нагруженных полидатином хитозановых наночастиц у крыс с сахарным диабетом: модуляция метаболизма глюкозы, окислительного стресса и биомаркеров воспалительных процессов. Биохимия 2021; 86(2): 214 doi: 10.31857/S0320972521020068
|
| 21 |
Zobair M. Younossi, Linda Henry. Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma. JHEP Reports 2021; 3(4): 100305 doi: 10.1016/j.jhepr.2021.100305
|
| 22 |
Tushar Prabhakar, Kanica Kaushal, Manya Prasad, Ekta Gupta, Ajit Sood, Ajay K. Jain, Akash Shukla, Ashish Goel, Ajay Duseja, Anoop Saraya, Samir Shah, Guresh Kumar, Shiv Kumar Sarin. Etiologic fractions in patients of hepatocellular carcinoma in India with and without a background of cirrhosis: a multi-centric study. Hepatology International 2023; 17(3): 745 doi: 10.1007/s12072-023-10498-w
|
| 23 |
Aakash Desai, Sonia Sandhu, Jin-Ping Lai, Dalbir Singh Sandhu. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. World Journal of Hepatology 2019; 11(1): 1-18 doi: 10.4254/wjh.v11.i1.1
|
| 24 |
Caitlin A. McIntyre, Joanne F. Chou, Mithat Gonen, Jinru Shia, Maya Gambarin-Gelwan, Vinod P. Balachandran, T. Peter Kingham, Peter J. Allen, Jeffrey A. Drebin, William R. Jarnagin, Michael I. D'Angelica. Hepatocellular carcinoma in patients with no identifiable risk factors. HPB 2021; 23(1): 118 doi: 10.1016/j.hpb.2020.05.005
|
| 25 |
Vasyl Prysyazhnyuk, Larysa Sydorchuk, Ruslan Sydorchuk, Iryna Prysiazhniuk, Kateryna Bobkovych, Inna Buzdugan, Valentina Dzuryak, Petro Prysyazhnyuk. Glutathione-S-transferases genes-promising predictors of hepatic dysfunction. World Journal of Hepatology 2021; 13(6): 620-633 doi: 10.4254/wjh.v13.i6.620
|
| 26 |
Annalisa Cespiati, Felice Cinque, Marica Meroni, Rosa Lombardi, Paola Dongiovanni, Anna Ludovica Fracanzani. An Overview of Hepatocellular Carcinoma Surveillance Focusing on Non-Cirrhotic NAFLD Patients: A Challenge for Physicians. Biomedicines 2023; 11(2): 586 doi: 10.3390/biomedicines11020586
|
| 27 |
Y. E. Chon, K. S. Jung, M.‐J. Kim, J.‐Y. Choi, C. An, J. Y. Park, S. H. Ahn, B. K. Kim, S. U. Kim, H. Park, S. K. Hwang, K. S. Rim, K.‐H. Han, D. Y. Kim. Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance. Alimentary Pharmacology & Therapeutics 2018; 47(8): 1201 doi: 10.1111/apt.14578
|
| 28 |
Zurabi Lominadze, Mohammed Rifat Shaik, Dabin Choi, Duha Zaffar, Lopa Mishra, Kirti Shetty. Hepatocellular Carcinoma Genetic Classification. The Cancer Journal 2023; 29(5): 249 doi: 10.1097/PPO.0000000000000682
|
| 29 |
Zobair M. Younossi, Linda Henry, Scott Isaacs, Kenneth Cusi. Identification of High-Risk Patients With Nonalcoholic Fatty Liver Disease in Endocrinology Clinics. Endocrine Practice 2023; 29(11): 912 doi: 10.1016/j.eprac.2023.06.012
|
| 30 |
V. Prysyazhnyuk. Clinical-pathagenetic, Age, Gender, Genetic Aspects of Non-alcoholic Fatty Liver Disease and Nonviral Chronic Hepatitis Without, and also with Comorbid Hypothyroidism; Improving of Their Treatment. Lviv clinical bulletin 2018; 3(23): 8 doi: 10.25040/lkv2018.03.008
|
| 31 |
K. Reyes-Gordillo, R. Shah, M.R. Lakshman, R.E. Flores-Beltrán, P. Muriel. Liver Pathophysiology. 2017; : 687 doi: 10.1016/B978-0-12-804274-8.00049-7
|
| 32 |
Yilin Tian, Jing Lu, Yongxia Qiao. A metabolism-associated gene signature for prognosis prediction of hepatocellular carcinoma. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.988323
|
| 33 |
Lai Xue, Kun Wu, Hongmei Qiu, Bo Huang, Rongchun Chen, Wei Xie, Qingsong Jiang. Polydatin exhibits the hepatoprotective effects through PPAR-α/-β signaling pathway in Streptozocin-induced diabetic mice. Journal of Functional Foods 2017; 36: 341 doi: 10.1016/j.jff.2017.07.015
|